According to the results of the Rosetta Cartesian_ddG and Flex_ddG, we manually checked the PV2 and PV3 variants predicted to be highly stable, exhibit low binding free energy and are located outside the CDR regions, and those having pAcF facing outward were selected for experimental characterization, including PV2 variants S8pAcF, S26pAcF, S71pAcF, S74pAcF, Q82pAcF, S85pAcF and PV3 variants S8pAcF, S26pAcF, S71pAcF, N77pAcF, S85pAcF, K87pAcF (Fig
Additional non-oral contraception is advised for 4 weeks after starting treatment and after each dose escalation
Individuals on the highest 15mg dose achieved an average 20.9% reduction in body weight compared to 14.9% for those on 2.4mg of Semaglutide
Take only as directed
Patients should maintain consistent tirzepatide therapy during prednisone treatment rather than discontinuing it, and focus on structured nutrition and activity strategies to minimize corticosteroid-related weight gain